Skip Nav Destination
Issues
KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis
Ashley N. Sigafoos; Ezequiel J. Tolosa; Ryan M. Carr; Maite G. Fernandez-Barrena; Luciana L. Almada; David R. Pease; Tara L. Hogenson; Glancis L. Raja Arul; Fatemeh Mousavi; Sandhya Sen; Renzo E. Vera; David L. Marks; Luis F. Flores; Kayla C. LaRue-Nolan; Chen Wu; William R. Bamlet; Anne M. Vrabel; Hugues Sicotte; Erin L. Schenk; Thomas C. Smyrk; Lizhi Zhang; Kari G. Rabe; Ann L. Oberg; Peter G. Zaphiropoulos; Eric Chevet; Rondell P. Graham; Catherine E. Hagen; Marina P. di Magliano; Sherine F. Elsawa; Christopher L. Pin; Junhao Mao; Robert R. McWilliams; Martin E. Fernandez-Zapico
The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal Cancer
Martin Benej; Rebecca Hoyd; McKenzie Kreamer; Caroline E. Wheeler; Dennis J. Grencewicz; Fouad Choueiry; Carlos H.F. Chan; Yousef Zakharia; Qin Ma; Rebecca D. Dodd; Cornelia M. Ulrich; Sheetal Hardikar; Michelle L. Churchman; Ahmad A. Tarhini; Lary A. Robinson; Eric A. Singer; Alexandra P. Ikeguchi; Martin D. McCarter; Gabriel Tinoco; Marium Husain; Ning Jin; Aik C. Tan; Afaf E.G. Osman; Islam Eljilany; Gregory Riedlinger; Bryan P. Schneider; Katarina Benejova; Martin Kery; Ioanna Papandreou; Jiangjiang Zhu; Nicholas Denko; Daniel Spakowicz; for the exORIEN Consortium
Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate–Resistant Prostate Cancer
Elisabeth I. Heath; Archana Thakur; Wei Chen; Clara Hwang; Channing J. Paller; Frank C. Cackowski; Julie L. Boerner; Lance Heilbrun; Melanie P. Smith; Dana L. Schalk; Amy Schienschang; Sarah A. Whitaker; Amanda Polend; Daryn Smith; Ulka N. Vaishampayan; Brenda Dickow; Lawrence G. Lum
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma
Edgar Gonzalez-Kozlova; Hsin-Hui Huang; Opeyemi A. Jagede; Kevin Tuballes; Diane M. Del Valle; Geoffrey Kelly; Manishkumar Patel; Hui Xie; Jocelyn Harris; Kimberly Argueta; Kai Nie; Vanessa Barcessat; Radim Moravec; Jennifer Altreuter; Dzifa Y. Duose; Brad S. Kahl; Stephen M. Ansell; Joyce Yu; Ethan Cerami; James R. Lindsay; Ignacio I. Wistuba; Seunghee Kim-Schulze; Catherine S. Diefenbach; Sacha Gnjatic
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma
Sun M. Lim; Seong-san Kang; Dong K. Kim; Soo-Hwan Lee; Chun-Bong Synn; Sujeong Baek; Seung M. Yang; Yu J. Han; Mi H. Kim; Heekyung Han; Kwangmin Na; Young T. Kim; Mi R. Yun; Jae H. Kim; Youngseon Byeon; Young S. Kim; Jii B. Lee; Min H. Hong; Joshua C. Curtin; Bharvin Patel; Isabelle Bergiers; Kyoung-Ho Pyo; Byoung C. Cho
Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures
Umair Mahmood; Andrew Blake; Sanjay Rathee; Leslie Samuel; Graeme Murray; David Sebag-Montefiore; Simon Gollins; Nicholas P. West; Rubina Begum; Simon P. Bach; Susan D. Richman; Phil Quirke; Keara L. Redmond; Manuel Salto-Tellez; Viktor H. Koelzer; Simon J. Leedham; Ian Tomlinson; Philip D. Dunne; Francesca M. Buffa; S:CORT consortium; Tim S. Maughan; Enric Domingo
Putrescine Supplementation Limits the Expansion of pks+ Escherichia coli and Tumor Development in the Colon
Manon Oliero; Thibault Cuisiniere; Ayodeji S. Ajayi; Claire Gerkins; Roy Hajjar; Gabriela Fragoso; Annie Calvé; Hervé Vennin Rendos; Annabelle Mathieu-Denoncourt; François Dagbert; Éric De Broux; Rasmy Loungnarath; Frank Schwenter; Herawaty Sebajang; Richard Ratelle; Ramses Wassef; Carole Richard; Marylise Duperthuy; Andrée E. Gravel; Antony T. Vincent; Manuela M. Santos
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170)
Edward Maldonado; W. Kimryn Rathmell; Geoffrey I. Shapiro; Naoko Takebe; Jordi Rodon; Devalingam Mahalingam; Nikolaos A. Trikalinos; Arash R. Kalebasty; Mamta Parikh; Scott A. Boerner; Celene Balido; Gregor Krings; Timothy F. Burns; Emily K. Bergsland; Pamela N. Munster; Alan Ashworth; Patricia LoRusso; Rahul R. Aggarwal
N-Myristoytransferase Inhibition Causes Mitochondrial Iron Overload and Parthanatos in TIM17A-Dependent Aggressive Lung Carcinoma
Sofia Geroyska; Isabel Mejia; Alfred A. Chan; Marian Navarrete; Vijaya Pandey; Samuel Kharpatin; Juliana Noguti; Feng Wang; Daniel Srole; Tsui-Fen Chou; James Wohlschlegel; Elizabeta Nemeth; Robert Damoiseaux; David B. Shackelford; Delphine J. Lee; Begoña Díaz
Epigenetic Induction of Cancer-Testis Antigens and Endogenous Retroviruses at Single-Cell Level Enhances Immune Recognition and Response in Glioma
Thomas J. Lai; Lu Sun; Kevin Li; Terry J. Prins; Janet Treger; Tie Li; Matthew Z. Sun; David A. Nathanson; Linda M. Liau; Albert Lai; Robert M. Prins; Richard G. Everson
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
Yusuke Goto; Keiichi Koshizuka; Toshinori Ando; Hiroki Izumi; Xingyu Wu; Kuniaki Sato; Tomohiko Ishikawa; Kyle Ford; Xiaodong Feng; Zhiyong Wang; Nadia Arang; Michael M. Allevato; Ayush Kishore; Prashant Mali; J. Silvio Gutkind
E2F1-Associated Purine Synthesis Pathway Is a Major Component of the MET-DNA Damage Response Network
Michaela Poliaková Turan; Rahel Riedo; Matúš Medo; Chiara Pozzato; Manja Friese-Hamim; Jonas P. Koch; Si’Ana A. Coggins; Qun Li; Baek Kim; Joachim Albers; Daniel M. Aebersold; Nicola Zamboni; Yitzhak Zimmer; Michaela Medová
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium
Jason W.-L. Eng; Yu Kato; Yusuke Adachi; Bhairavi Swaminathan; L.A. Naiche; Rahul Vadakath; Yoshimasa Sakamoto; Youya Nakazawa; Sho Tachino; Ken Ito; Takanori Abe; Yukinori Minoshima; Kana Hoshino-Negishi; Hideaki Ogasawara; Tomomi Kawakatsu; Miyuki Nishimura; Masahiko Katayama; Masashi Shimizu; Kazuhiro Tahara; Toshitaka Sato; Katsuhisa Suzuki; Kishan Agarwala; Masao Iwata; Kenichi Nomoto; Yoichi Ozawa; Toshio Imai; Yasuhiro Funahashi; Junji Matsui; Jan Kitajewski
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds